期刊文献+

CYP1A1*2A基因多态性与宁夏汉族乳腺癌遗传易感性研究 被引量:7

Study of CYP1A1 *2A Gene Polymorphism and Susceptibility to Breast Cancer in the Han Nationality in Ningxia
下载PDF
导出
摘要 [目的]分析宁夏汉族CYP1A1*2A基因多态性与乳腺癌遗传易感性的关系。[方法]应用聚合酶链反应—限制性片段长度多态性(PCR-RFLP)技术分别对144例乳腺癌患者和154例对照的CYP1A1*2A基因多态性进行测定,分析两组基因型及等位基因频率的分布特点。[结果]CYP1A1*2A等位基因T、C在乳腺癌组和对照组分布的差异无显著性(P>0.05),其中等位基因C的乳腺癌发病风险比值比(OR)为1.34(95%CI:0.97~1.86)。CYP1A1*2A各基因型分布两组间差异也无显著性(P>0.05),杂合子突变TC、纯合子突变CC分别与野生型TT相比,乳腺癌发病风险OR分别为1.32(95%CI:0.80~2.18)和1.86(95%CI:0.92~3.78)。[结论]CYP1A1*2A基因多态性其突变纯合子和杂合子有增加乳腺癌风险的趋势,但未达到显著水平。CYP1A1*2A基因多态性可能与宁夏汉族人群乳腺癌的发病有关系。 [Purpose] To investigate the association between CYP1A1*2A gene polymorphism and its susceptibility to breast cancer in the Han nationality in Ningxia. [Methods] CYP1A1 *2A gene polymorphism in 144 cases with breast cancer and 154 controls were detected by PCR-RFLP. The frequencies of genotype and allele were analyzed. [Results] The frequencies of allele T and C showed no significant difference between the two groups (P〉0.05). The odds ratio (OR) of breast cancer with the allele C was 1.34(95%CI: 0.97-1.86). There was no significant difference in the genotype TT, TC, CC between the two groups (P〉 0.05) too. Compared to wild type TT, the OR of breast cancer with genotypes of heterozygote TC and homozygote CC were 1.32(95%CI: 0.80-2.18) and 1.86(95%CI: 0.92-3.78), respectively. [Conclusion] It is possible that the CYP1A1*2A gene polymorphism is linked with breast cancer in the Han nationality in Ningxia. Homozygote and heterozygote might increase risk for breast cancer, but without significant between breast cancer and controls.
出处 《中国肿瘤》 CAS 2007年第9期686-688,共3页 China Cancer
基金 宁夏回族自治区自然科学基金(NZ0530)
关键词 乳腺肿瘤 细胞色素p4501A1*2A 基因多态性 宁夏 汉族 breast neoplasms cytochrome P450 1A1*2A gene polymorphism Ningxia Han population
  • 相关文献

参考文献9

  • 1Henderson IC.Risk factors for breast cancer development[J].Cancer,1993,71(6 Suppl):2127-2140.
  • 2Crewe HK,Notley LM,Wunsch RM,et al.Metabolism of tamoxifen by recombinant human cytochrome p450 enzymes:formation of the 4-hydroxy,4'-hydroxy and Ndesmethyl metabolites and isomerization of trans-4-hydroxytamoxifen[J].Drug Metab Dispos,2002,30(8):869-874.
  • 3Taioli E,Trachman J,Chen X,et al.A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women[J].Cancer Res,1995,55(17):3757-3758.
  • 4Masson LF,Sharp L,Cotton SC,et al.Cytochrome P450 1A1 gene polymorphisms and risk of breast cancer:A HuGE review[J].Am J Epidemiol,2005,161(10):901-915.
  • 5Alexandie AK,Warholm M,Carstensen U,et al.CYPlAl and GSTM1 polymorphisms affect urinary 1-hydroxypyrene levels after PAH exposure[J].Carcinogenesis,2000,21(4):669-676.
  • 6Bailey LR,Roodi N,Verrier CS,et al.Breast cancer and CYPIA1 GSTM1,and GSTT1 polymorphisms:evidence of a lack of association in Caucasians and African Americans[J].Cancer Res,1998,58(1):65-70.
  • 7Ishibe N,Hankinson SE,Colditz GA,et al.Cigarette smoking,cytochrome P450 1A1 polymorphisms,and breast cancer risk in the Nurses'Health Study[J].Cancer Res,1998,58(4):667-671.
  • 8Miyoshi Y,Takahashi Y,Egawa C,et al.Breast cancer risk associated with CYP1A1 genetic polymorphisms in Japanese women[J].Breast J,2002,8(4):209-215.
  • 9Ambrosone CB,Freudenheim JL,Graham S,et al.Cytochrome P4501A1 and glutathione S-transferase(M1) genetic polymorphisms and postmenopausal breast cancer risk[J].Cancer Res,1995,55(16):3483-3485.

同被引文献116

引证文献7

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部